Search Results

Containing any of the words

Only of the type

Insulin Glargine 100 units/mL + Lixisenatide Risk Minimization Activity - New

SFDA: Submissions for Research Day 2024 Still Open News

A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with type 2 diabetes, hypertension and established cardiovascular disease (EASi-PROTKT™) Drug Clinical Trial

Guidance for ISO 13485 Requirements and Corresponding SFDA-MDS Requirements (MDS-G024) Regulations

SFDA: Over 469 Drug Registration Requests Submitted through SDR System in the First Half of 2024 News

SFDA: “ E129 & E110 Colours are allowed to be used, with a statement advising that they may affect Children” Warnings

(SG-1801-01-H) Update - Urgent FSN of Absorb and Absorb GT1 (BVS) Systems manufactured by Abbott with list Medical Report

A FARAPULSE Pulsed Field Ablation ProspectiVE RegiStry in REal Life Utilization (PF115),Sub-Study: FARAWAY: The FARAPULSE Workflow Assessment Registry (PF117) Clinical Trial

What does mean, “The timeframe for returned MDMA application is 60 calendar days” in announcement (8) 8/2019? FAQ

(SG-1903-15-H) Potential Risks associated with Vial2Bag Fluid Transfer Sets May Result in Patient Harm Medical Report